Global Market Pipeline for Vaccine Technologies 2024-2028

DUBLIN, Feb. 8, 2024 /PRNewswire/ — The “Global Markets for Vaccine Technologies” report has been added to ResearchAndMarkets.com’s offering.

Advancements will occur in regard to the development of novel vaccines towards emerging infectious diseases, cancers and allergies. Continuous improvements in vaccine design, delivery technologies and manufacturing will also boost market growth.

The global vaccine technologies market is segmented in this report by technology, disease, age, and region. This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.

This report includes only human vaccines; animal vaccines have not been considered in this report. This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.

Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs.

The market has been analyzed based on the application of current vaccines. Categories considered in this report include pneumococcal vaccines; diphtheria, tetanus vaccines; HPV vaccines; MMR vaccines; and other vaccines including rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, polio vaccines, BCG, and yellow fever vaccines.

This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.

This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful.

The Report Includes

34 data tables and 63 additional tablesAn up-to-date overview of the global markets for vaccine technologiesAnalyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028Estimate of the market size and revenue forecast for the global market, and a corresponding market share analysis based on technology, disease indication, age group and regionFacts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, global R&D spending, and the regulatory landscapeAssessment of present and future strategies in the innovation-driven vaccine technologies market, and a look at the vaccines for humans and their immunization scheduleDiscussion of the importance of ESG in the market for vaccine technologies, including consumer attitudes, the impact of ESG factors on company performance, and ESG practices of leading companiesReview of patents and patent applicationsOverview of the major vendors, along with an analysis of the industry structure, including company market shares, recent M&A activity, and venture fundingAnalysis of the competitive landscape based on recent developments and segmental revenuesProfiles of the leading companies

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Immune System and VaccinesComponents of the Immune SystemCells of the Immune SystemImmune ResponseMajor Histocompatibility Complex (MHC)Immunization and VaccinesDisorders of the Immune SystemImpact of Lifestyle on the Immune SystemHow Vaccines WorkPrinciples of ImmunizationTypes of ImmunityAdvantages of VaccinationHistory of VaccinesVaccines and Immunization, OverviewTypes of VaccinesAttenuated (Live) VaccinesInactivated (Killed) VaccinesToxoid VaccinesSubunit VaccinesConjugate VaccinesRecombinant Vector VaccinesDNA VaccinesRNA VaccinesImmunizationAdvantages of ImmunizationAdjuvants and ExcipientsPathogen ComponentsParticulate AdjuvantsInfectious Diseases Preventable by VaccineHuman DiseasesViral DiseasesBacterial DiseasesRegulatory AspectsWorld Health Organization (WHO) Prequalified VaccinesNew Product ApprovalsRecallsSignificant Regulatory Developments in Vaccines

Chapter 4 Market Dynamics

Market DriversGrowing Awareness of ImmunizationGrowing Investments and R&DNew VaccinesPrevalence of Infectious DiseasesMarket RestraintsVaccine Development and PricingMarket OpportunitiesIncreased Demand from Emerging MarketsTherapeutic Vaccines

Chapter 5 Global Market for COVID-19 Vaccines

COVID-19 Vaccine TechnologiesAdvent of mRNA TechnologyImpact of COVID-19 on Routine Infant VaccinationCOVID-19 DisruptionsStagnating Global Coverage RateProgress and Challenges by Country and Region

Chapter 6 Market Breakdown by Technology

Subunit, Recombinant, Polysaccharide, and Conjugate VaccinesLive-Attenuated VaccinesInactivated VaccinesToxoid VaccinesOther/Combination Vaccines

Chapter 7 Market Breakdown by Disease

PneumococcalDiphtheria and TetanusHPVMMR

Chapter 8 Market Breakdown by Age Group

PediatricsAdolescents and Adults

Chapter 9 Market Breakdown by Region

Chapter 10 Emerging Technologies and Developments

DevelopmentsmRNA VaccinesViral Vector VaccinesNanoparticle VaccinesDNA VaccinesVirus-Like Particle (VLP) VaccinesSelf-Amplifying RNA VaccinesInnovative AdjuvantsAI and Computational BiologyPersonalized VaccinesPlant-Based Vaccines

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

AbbottAstrazenecaBavarian NordicBharat Biotech InternationalEmergent BiosolutionsGSKJohnson & Johnson ServicesMerckMitsubishi Tanabe Pharma Corp.Panacea BiotecPfizer Inc.Sanofi

For more information about this report visit https://www.researchandmarkets.com/r/squdpk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/global-market-pipeline-for-vaccine-technologies-2024-2028-302057376.html

SOURCE Research and Markets